Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (123)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3723)
  2. Department of Medicine (3692)
  3. Hematologic Malignancies, Division of (3688)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (106)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (326)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3723)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukaemia: Final 5-year results from the BFORE trial
    Meeting Abstract

    Milojkovic, D.; Brümmendorf, T. H.; Cortes, J. E.; Gambacorti-Passerini, C.; Clark, R. E.; Le Coutre, P.; García-Gutierrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse
    Journal Article

    Hu, R.; Wei, W.; Mian, A.; Gonter-Aubin, K.; Kabel, C.; Mato, A.; Stephens, D. M.; Hanlon, A.; Khajavian, S.; Shadman, M.; more...
    European Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
    Journal Article

    Miltiadous, O.; Waters, N. R.; Andrlová, H.; Dai, A.; Nguyen, C. L.; Burgos da Silva, M.; Lindner, S.; Slingerland, J.; Giardina, P.; Clurman, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Treatment of patients with acute myeloid leukemia with the targeted alpha-particle nanogenerator (225)actinium-lintuzumab
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Carrasquillo, J. A.; Pandit-Taskar, N.; Frattini, M. G.; Maslak, P. G.; Park, J. H.; Douer, D.; Cicic, D.; Larson, S. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis
    Review

    Nocco, S.; Andriano, T. M.; Bose, A.; Chilov, M.; Godwin, K.; Dranitsaris, G.; Wu, S.; Lacouture, M. E.; Roeker, L. E.; Mato, A. R.; more...
    Critical Reviews in Oncology/Hematology (2022)

    Fulltext@MSK | Save
  • The CXCR1/CXCR2 inhibitor reparixin alters the development of myelofibrosis in the Gata1(low) mice
    Journal Article

    Verachi, P.; Gobbo, F.; Martelli, F.; Martinelli, A.; Sarli, G.; Dunbar, A.; Levine, R. L.; Hoffman, R.; Massucci, M. T.; Brandolini, L.; more...
    Frontiers in Oncology (2022)

    Fulltext@MSK | Save
  • Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
    Journal Article

    Wang, X.; Rampal, R. K.; Hu, C. S.; Tripodi, J.; Farnoud, N.; Petersen, B.; Rossi, M. R.; Patel, M.; McGovern, E.; Najfeld, V.; more...
    JCI Insight (2022)

    Fulltext@MSK | Save
  • SWOG 1318: A phase II trial of blinatumomab followed by POMP maintenance in older patients with newly diagnosed philadelphia chromosome-negative B-cell acute lymphoblastic leukemia
    Journal Article

    Advani, A. S.; Moseley, A.; O'Dwyer, K. M.; Wood, B. L.; Fang, M.; Wieduwilt, M. J.; Aldoss, I.; Park, J. H.; Klisovic, R. B.; Baer, M. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Hematopoietic growth factors, version 1.2022: Featured updates to the NCCN Guidelines
    Guidelines

    Griffiths, E. A.; Roy, V.; Alwan, L.; Bachiashvili, K.; Baird, J.; Cool, R.; Dinner, S.; Geyer, M.; Glaspy, J.; Gojo, I.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save